A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

A groundbreaking study by researchers at Wuhan University, China, has identified a cholesterol metabolite that plays a ...

Broking analysts have lowered their expectations on Cochlear, but in the main their valuations are above the current share ...

A woman was given an artificial intelligence device to help her speak following a diagnosis of motor neurone disease – but it ...

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...

Evrysdi is a survival motor neuron 2 (SMN2) pre-mRNA splicing modifier designed ... to the function of nerves that control ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice.